Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators

Autor: Samo Guzelj, Matjaž Weiss, Bram Slütter, Ruža Frkanec, Žiga Jakopin
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Journal of medicinal chemistry, vol. 65, no. 22, 2022.
ISSN: 1520-4804
Popis: The success of vaccination with subunit vaccines often relies on the careful choice of adjuvants. There is great interest in developing new adjuvants that can elicit a cellular immune response. Here, we address this challenge by taking advantage of the synergistic cross-talk between two pattern recognition receptors: nucleotide-binding oligomerization-domain- containing protein 2 (NOD2) and Toll-like receptor 7 (TLR7). We designed two conjugated NOD2/TLR7 agonists, which showed potent immunostimulatory activities in human primary peripheral blood mononuclear cells and murine bone-marrow-derived dendritic cells. One of these, 4, also generated a strong antigen-specific immune response in vivo, with a Th1-polarized profile. Importantly, our study shows that novel NOD2/TLR7 agonists elicit sophisticated and fine-tuned immune responses that are inaccessible to individual NOD2 and TLR7 agonists.
Databáze: OpenAIRE